NASDAQ: CYTKCytokinetics Inc Stock Forecast, Predictions & Price Target
Analyst price target for CYTK
Based on 9 analysts offering 12 month price targets for Cytokinetics Inc.
Min Forecast
$49.00+75.75%
Avg Forecast
$58.33+109.23%
Max Forecast
$71.00+154.66%
Should I buy or sell CYTK stock?
Based on 9 analysts offering ratings for Cytokinetics Inc.
Strong Buy
Strong Buy
4 analysts 44.44%
Buy
5 analysts 55.56%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Be the first to know when Wall Street analysts revise their CYTK stock forecasts and price targets.
CYTK stock forecasts by analyst
| Analyst / Firm | Rating | Action | Price Target | Upside/Downside | Date | Analyst Color |
|---|---|---|---|---|---|---|
| Strong Buy | Reiterates | $59.00 | +111.62% | 2023-08-22 | ||
| Buy | Initiates Coverage On | $58.00 | +108.03% | 2023-08-15 | ||
| Buy | Reiterates | $60.00 | +115.21% | 2023-08-04 | ||
| Strong Buy | Reiterates | $60.00 | +115.21% | 2023-08-04 | ||
| Buy | Reiterates | $49.00 | +75.75% | 2023-08-04 | ||
| Buy | Reiterates | $71.00 | +154.66% | 2023-05-22 | ||
| Buy | Reiterates | $54.00 | +93.69% | 2023-05-16 | ||
| Strong Buy | Maintains | $53.00 | +90.10% | 2023-05-05 | ||
| Strong Buy | Maintains | $61.00 | +118.79% | 2023-04-03 |
Forecast return on equity
Is CYTK forecast to generate an efficient return?
Insufficient data to display
Forecast return on assets
Is CYTK forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%
CYTK revenue growth forecast
How is CYTK forecast to perform vs Biotechnology companies and vs the US market?
Company
225.18%
Industry
34.31%
Market
8.24%
CYTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CYTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast
CYTK vs Biotech Stocks
Cytokinetics Stock Forecast FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.